Vodafone Idea Limited (Vi) has officially dismissed recent media reports claiming that the US-based private equity firm Tillman Global Holdings (TGH) is planning to invest USD 6 billion in the telecom ...

In a scene that redefines the standards of wealth and influence in the 21st century, The Wall Street Journal revealed in an ...

The domination of the United States by a parasitic oligarchy, whose seat of power is in the White House, is on display for ...

Bitcoin's key $106,900 support bounced bulls once, but with bearish daily charts and Nasdaq drags, a plunge to $96,000 feels inevitable unless buyers fight back now.

Experts believe that AI will grow into a multitrillion-dollar industry. It's exciting, to say the least. But much of AI's ...

Tuesday's New York mayoral race outcome will inevitably determine a just-in-time or all-too-late wake-up call to prevent ...

Freshpet is scaling back its expansion-related spending to $140 million from $175 million to account for these macroeconomic ...

UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround ...

Cisco launched new AI-driven innovations for enterprise value, including Unified Edge platform and AI-ready network architecture, to simplify operations, strengthen security, and accelerate ...

Plus, it's a season of mixed results for Chinese automakers like BYD and Xpeng, and the world may get relief from the Nexperia chip shortage.

Iovance Biotherapeutics shares rose after the company received positive data from a clinical trial of its cancer treatment. Shares traded 11% higher ahead of the morning bell at $2.18.

ASX-listed tech companies have released their latest quarterly results, showing solid progress across key areas.